Surmodics, Inc. Common Stock (SRDX)
Surmodics, Inc. is a provider of surface modification and medical device coating solutions primarily aimed at the interventional and surgical healthcare markets. The company develops and supplies innovative technologies to enhance the performance of medical devices, including those used in cardiovascular, peripheral, and surgical procedures. Founded in 1979 and headquartered in Eden Prairie, Minnesota, Surmodics operates through its divisions focused on coatings, drug delivery, and point-of-care diagnostics.
Company News
Raizen is exploring the sale of its Argentinian assets, Walgreens may go private in a $10 billion deal, and the U.S. government is considering acquiring TikTok's U.S. business amid a deadline. Meanwhile, Onsemi increased its bid for Allegro Microsystems, and American Express agreed to acquire Center.
The biocompatible coating market is expected to grow significantly due to increased demand for medical implants and devices, advancements in nanotechnology, and rising prevalence of chronic diseases requiring medical interventions.
Surmodics (SRDX) inks the group purchasing agreement for its thrombectomy products with Premier.
The company gained FDA marketing approval for a drug-coated balloon that will help clear blocked arteries.